Quick Answer
BIOREGENX, INC. reported Long-Term Debt of $0.00 for fiscal year 2023.
BIOREGENX, INC. Long-Term Debt — Annual History
| Fiscal Year | Long-Term Debt | YoY Change |
|---|---|---|
| 2023 | $0.00 | -100.0% |
| 2022 | $195.8K | -1.0% |
| 2021 | $197.8K | — |
Quarterly Long-Term Debt
| Quarter Ending | Long-Term Debt | YoY | QoQ |
|---|---|---|---|
| September 30, 2023 | $0.00 | — | -100.0% |
| June 30, 2023 | $195.8K | — | +0.0% |
| March 31, 2023 | $195.8K | — | +0.0% |
| December 31, 2022 | $195.8K | — | — |
- BIOREGENX, INC. showed a decrease of -100.0% in Long-Term Debt compared to the prior fiscal year.
- Over the 2021–2023 period, BIOREGENX, INC.’s long-term debt has declined by 100.0% (from $197.8 thousand to $0.00).
- The most recent figure is from BIOREGENX, INC.’s fiscal year 2023 report (Form 10-K), filed with the SEC on April 12, 2024.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: